Abcam Life Science Reagents 2023 Growth Conference Presentation

Abcam is a leader in life science research reagents with £362M in 2022 revenues and adjusted gross margins exceeding 75%. The company generates 100% recurring revenues with 67% derived from in-house products, maintaining complete exposure to life sciences markets. This presentation outlines resilient growth strategies amid challenging market conditions.